VERICEL CORPORATION Deferred Rent Credit, Noncurrent
VERICEL CORPORATION (VCEL) had Deferred Rent Credit, Noncurrent of $134.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:DeferredRentCreditNoncurrent · last filed 2019-08-06
- 2019-06-30: Deferred Rent Credit, Noncurrent $134.00K.
- 2019-03-31: Deferred Rent Credit, Noncurrent $133.00K.
- 2018-12-31: Deferred Rent Credit, Noncurrent $1.67M.
- 2018-09-30: Deferred Rent Credit, Noncurrent $1.81M.
| Period end | Deferred Rent Credit, Noncurrent |
|---|---|
| 2019-06-30 | $134.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $133.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.67M 10-Q · filed 2019-08-06 |
| 2018-09-30 | $1.81M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.96M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $1.95M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.06M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $1.61M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.57M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.63M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.69M 10-Q · filed 2017-11-07 |
| 2016-09-30 | $1.23M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $820.00K 10-Q · filed 2016-08-08 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |